HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen W Barthold Selected Research

Interferon Type I

4/2014MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen W Barthold Research Topics

Disease

26Infections
11/2023 - 03/2002
13Lyme Disease (Disease, Lyme)
11/2023 - 06/2002
6Arthritis (Polyarthritis)
05/2013 - 06/2002
5Inflammation (Inflammations)
01/2014 - 11/2002
3Bacteremia
11/2023 - 04/2003
2Persistent Infection
08/2013 - 11/2002
2Myocarditis (Carditis)
05/2013 - 08/2006
1Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1Tick-Borne Diseases (Tick-Borne Disease)
05/2013
1Diarrhea
04/2005
1Helicobacter Infections
02/2004
1Hemorrhage
04/2003
1Rheumatoid Arthritis
11/2002
1Communicable Diseases (Infectious Diseases)
10/2002
1Leukopenia
03/2002
1Ehrlichiosis
03/2002

Drug/Important Bio-Agent (IBA)

7Anti-Bacterial Agents (Antibiotics)IBA
01/2014 - 11/2002
6AntigensIBA
05/2011 - 02/2004
5Proteins (Proteins, Gene)FDA Link
01/2015 - 12/2003
5CytokinesIBA
01/2014 - 03/2002
4VaccinesIBA
01/2016 - 06/2007
3Messenger RNA (mRNA)IBA
10/2013 - 11/2002
34,5-dibromo-2-pyrrolic acidIBA
05/2013 - 07/2002
2Immunoglobulin M (IgM)IBA
11/2023 - 06/2004
2Immunoglobulin G (IgG)IBA
11/2023 - 06/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2013 - 12/2007
2DecorinIBA
08/2013 - 05/2013
2Membrane Proteins (Integral Membrane Proteins)IBA
05/2013 - 06/2007
2Immune Sera (Antisera)IBA
08/2006 - 12/2003
2DNA (Deoxyribonucleic Acid)IBA
08/2006 - 04/2003
2AntibodiesIBA
06/2004 - 12/2003
2Eosine Yellowish-(YS) (Eosin)IBA
02/2004 - 12/2003
2Hematoxylin (Haematoxylon)IBA
02/2004 - 12/2003
2IntegrinsIBA
04/2003 - 03/2002
1LuciferasesIBA
01/2015
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
04/2014
1Interferon Type IIBA
04/2014
1Interleukin-10 (Interleukin 10)IBA
10/2013
1Carrier Proteins (Binding Protein)IBA
05/2013
1Virulence Factors (Pathogenicity Factors)IBA
07/2012
1CL 331002 (glycylcycline)IBA
02/2010
1Tigecycline (Tygacil)FDA Link
02/2010
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
05/2008
1Saline SolutionIBA
05/2008
1Bacterial AntigensIBA
06/2007
1RNA (Ribonucleic Acid)IBA
08/2006
1OspA proteinIBA
06/2005
1Differentiation AntigensIBA
06/2004
1Immunoglobulins (Immunoglobulin)IBA
06/2004
1Bacterial LysatesIBA
02/2004
1EnzymesIBA
02/2004
1EpitopesIBA
12/2003
1Peptide FragmentsIBA
12/2003
1Complement System Proteins (Complement)IBA
12/2003
1salicylhydroxamic acid (SHAM)IBA
11/2002
1Protein Isoforms (Isoforms)IBA
11/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2002
11-oleoyl-2-stearoylphosphatidylcholineIBA
07/2002
1p38 Mitogen-Activated Protein KinasesIBA
06/2002
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2002
1Phosphotransferases (Kinase)IBA
06/2002

Therapy/Procedure

2Therapeutics
01/2012 - 11/2002
2Transplantation
02/2010 - 05/2008
2Microspheres (Microsphere)
04/2005 - 11/2004
1Immunomodulation
11/2013
1Aftercare (After-Treatment)
02/2010